Cargando…

Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer

Hepatocellular carcinoma (HCC) is the third deadliest and sixth most common cancer in the world. Histone‐lysine N‐methyltransferase EHMT2 (also known as G9a) is a histone methyltransferase frequently overexpressed in many cancer types, including HCC. We showed that Myc‐driven liver tumours have a un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thng, Dexter Kai Hao, Hooi, Lissa, Toh, Clarissa Chin Min, Lim, Jhin Jieh, Rajagopalan, Deepa, Syariff, Imran Qamar Charles, Tan, Zher Min, Rashid, Masturah Bte Mohd Abdul, Zhou, Lei, Kow, Alfred Wei Chieh, Bonney, Glenn Kunnath, Goh, Brian Kim Poh, Kam, Juinn Huar, Jha, Sudhakar, Dan, Yock Young, Chow, Pierce Kah Hoe, Toh, Tan Boon, Chow, Edward Kai‐Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620125/ https://www.ncbi.nlm.nih.gov/pubmed/36896891 http://dx.doi.org/10.1002/1878-0261.13417

Ejemplares similares

Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC‐driven hepatocellular carcinoma
por: Thng, Dexter Kai Hao, et al.
Publicado: (2022)

Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
por: Lim, Jhin Jieh, et al.
Publicado: (2022)

Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression
por: Chong, Yong Chun, et al.
Publicado: (2020)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma
por: Zhang, Xi Yun, et al.
Publicado: (2020)

Epigenetics in cancer stem cells
por: Toh, Tan Boon, et al.
Publicado: (2017)

Epigenetics of hepatocellular carcinoma
por: Toh, Tan Boon, et al.
Publicado: (2019)

Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
por: Lim, Jhin Jieh, et al.
Publicado: (2022)

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel
por: Fong, Eliza Li Shan, et al.
Publicado: (2018)

Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
por: Wang, Xin, et al.
Publicado: (2014)

Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer
por: Tay, Daryl Jin Tai, et al.
Publicado: (2021)

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
por: Zhao, Yue, et al.
Publicado: (2018)

Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy
por: Kang, Zhihua, et al.
Publicado: (2023)

Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells
por: Toh, Tan-Boon, et al.
Publicado: (2014)

Analogues of the natural product Sinefungin as potent inhibitors of EHMT1 and EHMT2
por: Devkota, Kanchan, et al.
Publicado: (2013)

Cholecystectomy during the COVID-19 pandemic: Current evidence and an understanding of the ‘new’ critical view of safety: Correspondence
por: Kabir, Tousif, et al.
Publicado: (2020)

Primary malignant melanoma of the lower oesophagus presenting with dysphagia and upper gastrointestinal bleeding
por: Leong, Quor Meng, et al.
Publicado: (2008)

Safely Implementing a Program of Pure Laparoscopic Donor Right Hepatectomy: The Experience From a Southeast Asian Center
por: Law, Jia-Hao, et al.
Publicado: (2023)

TNFα Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1)
por: Able, Ashley A., et al.
Publicado: (2023)

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development
por: Blasiak, Agata, et al.
Publicado: (2020)

De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a
por: Vinson, David A., et al.
Publicado: (2022)

Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma
por: Chin, Ken Min, et al.
Publicado: (2018)

MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
por: Watanabe, Sugiko, et al.
Publicado: (2018)

Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma
por: Souza, Barbara Kunzler, et al.
Publicado: (2023)

Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence
por: Koh, Ye Xin, et al.
Publicado: (2018)

Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
por: Watson, Zachary L., et al.
Publicado: (2019)

Intragenic duplication of EHMT1 gene results in Kleefstra syndrome
por: Schwaibold, Eva Maria Christina, et al.
Publicado: (2014)

EHMT2 suppresses the variation of transcriptional switches in the mouse embryo
por: Zeng, Tie-Bo, et al.
Publicado: (2021)

Mechanisms of chemoresistance in cancer stem cells
por: Abdullah, Lissa Nurrul, et al.
Publicado: (2013)

Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer
por: Chow, Yock Ping, et al.
Publicado: (2022)

CDK2 regulates the NRF1/Ehmt1 axis during meiotic prophase I
por: Palmer, Nathan, et al.
Publicado: (2019)

Epigenetic Regulation of Learning and Memory by Drosophila EHMT/G9a
por: Kramer, Jamie M., et al.
Publicado: (2011)

Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2
por: Ang, Gareth Chin Khye, et al.
Publicado: (2022)

Outcome of minimally-invasive versus open pancreatectomies for solid pseudopapillary neoplasms of the pancreas: A 2:1 matched case-control study
por: Tan, Hwee Leong, et al.
Publicado: (2019)

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2022)

EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos
por: Auclair, Ghislain, et al.
Publicado: (2016)

Reversible white matter lesions associated with mutant EHMT1 and Kleefstra syndrome
por: He, Xu, et al.
Publicado: (2016)

Haploinsufficiency of EHMT1 improves pattern separation and increases hippocampal cell proliferation
por: Benevento, Marco, et al.
Publicado: (2017)

EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
por: Guo, Yuan, et al.
Publicado: (2021)

Revealing martensitic transformation and α/β interface evolution in electron beam melting three-dimensional-printed Ti-6Al-4V
por: Tan, Xipeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uoddr38dsn3h5c5btcbromhsub